Skip to main content
Top
Published in: Trials 1/2019

Open Access 01-12-2019 | Study protocol

Evaluation of a blended-learning training concept to train oncology physicians to advise their patients about complementary and integrative medicine (KOKON-KTO): study protocol for a prospective, multi-center, cluster-randomized trial

Authors: Stefanie M. Helmer, Alizé A. Rogge, Felix Fischer, Daniel Pach, Markus Horneber, Stephanie Roll, Claudia M. Witt

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Background

Many cancer patients are interested in complementary and integrative medicine during and after regular cancer treatment. Given the high number of users it is important that physicians and patients engage in a dialog about useful complementary and integrative medicine therapies during cancer treatment.
In a prospective, multi-center, cluster-randomized evaluation study we will develop, implement and evaluate a training program for oncology physicians advising their patients on complementary and integrative medicine. The main objective of the study is to evaluate whether training physicians in a blended-learning approach (e-learning + skills-training workshop) in providing advice to their cancer patients on complementary and integrative medicine, in addition to handing out an information leaflet about reputable websites, has different effects on the outcomes of patients, physicians, and their interaction level, compared to only giving out the information leaflet.

Methods/design

Forty-eight oncology physicians will be included into a cluster-randomized trial to either participate or not in the blended-learning training. Physicians will then advise 10 cancer patients each, resulting in 480 patients participating in the trial. The blended learning consists of nine units of up to 45 min of e-learning and 18 units of up to 45 min of on-site skills-training workshop focusing. Outcomes will be measured on the physician, patient, and physician-patient-interaction level.

Discussion

A blended-learning program for oncology physicians to advise their cancer patients in a systematic way and a reasonable time frame on complementary and integrative medicine will be evaluated in depth in a large cluster-randomized trial.

Trial registration

German Clinical Trials Register, ID: DRKS00012704. Registered on 28 August 2017.
Appendix
Available only for authorised users
Literature
1.
go back to reference Molassiotis A, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63.CrossRef Molassiotis A, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63.CrossRef
2.
go back to reference Hammer MJ, et al. Self-management for adult patients with cancer: an integrative review. Cancer Nurs. 2015;38(2):E10–26.CrossRef Hammer MJ, et al. Self-management for adult patients with cancer: an integrative review. Cancer Nurs. 2015;38(2):E10–26.CrossRef
3.
go back to reference Kessel KA, et al. Use of Complementary and Alternative Medicine (CAM) as part of the oncological treatment: survey about patients’ attitude towards CAM in a university-based oncology center in Germany. PLoS One. 2016;11(11):e0165801.CrossRef Kessel KA, et al. Use of Complementary and Alternative Medicine (CAM) as part of the oncological treatment: survey about patients’ attitude towards CAM in a university-based oncology center in Germany. PLoS One. 2016;11(11):e0165801.CrossRef
4.
go back to reference Horneber M, et al. How many cancer patients use complementary and alternative medicine? Integr Cancer Ther. 2012;11(3):187–203.CrossRef Horneber M, et al. How many cancer patients use complementary and alternative medicine? Integr Cancer Ther. 2012;11(3):187–203.CrossRef
5.
go back to reference Oskay-Ozcelik G, et al. Breast cancer patients’ expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol. 2007;18(3):479–84.CrossRef Oskay-Ozcelik G, et al. Breast cancer patients’ expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol. 2007;18(3):479–84.CrossRef
6.
go back to reference Evans M, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med. 2007;7:25.CrossRef Evans M, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med. 2007;7:25.CrossRef
7.
go back to reference Broom A, Tovey P. The role of the Internet in cancer patients’ engagement with complementary and alternative treatments. Health (London). 2008;12(2):139–55.CrossRef Broom A, Tovey P. The role of the Internet in cancer patients’ engagement with complementary and alternative treatments. Health (London). 2008;12(2):139–55.CrossRef
8.
go back to reference Holmes MM, Bishop FL, Calman L. “I just Googled and read everything”: exploring breast cancer survivors’ use of the Internet to find information on complementary medicine. Complement Ther Med. 2017;33:78–84.CrossRef Holmes MM, Bishop FL, Calman L. “I just Googled and read everything”: exploring breast cancer survivors’ use of the Internet to find information on complementary medicine. Complement Ther Med. 2017;33:78–84.CrossRef
9.
go back to reference Frenkel M, Cohen L. Effective communication about the use of complementary and integrative medicine in cancer care. J Altern Complement Med. 2014;20(1):12–8.CrossRef Frenkel M, Cohen L. Effective communication about the use of complementary and integrative medicine in cancer care. J Altern Complement Med. 2014;20(1):12–8.CrossRef
10.
go back to reference Tautz E, et al. Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer. 2012;48(17):3133–9.CrossRef Tautz E, et al. Use of complementary and alternative medicine in breast cancer patients and their experiences: a cross-sectional study. Eur J Cancer. 2012;48(17):3133–9.CrossRef
11.
go back to reference Juraskova I, et al. Discussing complementary therapy use with early-stage breast cancer patients: exploring the communication gap. Integr Cancer Ther. 2010;9(2):168–76.CrossRef Juraskova I, et al. Discussing complementary therapy use with early-stage breast cancer patients: exploring the communication gap. Integr Cancer Ther. 2010;9(2):168–76.CrossRef
12.
go back to reference Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women’s views, knowledge and interaction with doctors: a qualitative study. BMC Complement Altern Med. 2006;6(1):40.CrossRef Vickers KA, Jolly KB, Greenfield SM. Herbal medicine: women’s views, knowledge and interaction with doctors: a qualitative study. BMC Complement Altern Med. 2006;6(1):40.CrossRef
13.
go back to reference Arthur K, et al. Reasons to use and disclose use of complementary medicine use—An insight from cancer patients. Cancer Clin Oncol. 2013;2(2):81–92.PubMedPubMedCentral Arthur K, et al. Reasons to use and disclose use of complementary medicine use—An insight from cancer patients. Cancer Clin Oncol. 2013;2(2):81–92.PubMedPubMedCentral
14.
go back to reference Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004;12(2):90–8.CrossRef Robinson A, McGrail MR. Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004;12(2):90–8.CrossRef
15.
go back to reference Winslow C, Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med. 2002;162(10):1176–81.CrossRef Winslow C, Shapiro H. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med. 2002;162(10):1176–81.CrossRef
16.
go back to reference Guethlin C, Holmberg C, Klein G. Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis. Support Care Cancer. 2016;24(9):3857–62.CrossRef Guethlin C, Holmberg C, Klein G. Oncologists’ experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis. Support Care Cancer. 2016;24(9):3857–62.CrossRef
17.
go back to reference Klein GE, Guethlin C. Information and training needs regarding complementary and alternative medicine: a cross-sectional study of cancer care providers in Germany. Integr Cancer Ther. 2018;17(2):380–7. Klein GE, Guethlin C. Information and training needs regarding complementary and alternative medicine: a cross-sectional study of cancer care providers in Germany. Integr Cancer Ther. 2018;17(2):380–7.
18.
go back to reference Blödt S, et al. A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study. BMC Cancer. 2016;16:843.CrossRef Blödt S, et al. A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study. BMC Cancer. 2016;16:843.CrossRef
19.
go back to reference Kiessling C, et al. Development and validation of a computer-based situational judgement test to assess medical students’ communication skills in the field of shared decision making. Patient Educ Couns. 2016;99(11):1858–64.CrossRef Kiessling C, et al. Development and validation of a computer-based situational judgement test to assess medical students’ communication skills in the field of shared decision making. Patient Educ Couns. 2016;99(11):1858–64.CrossRef
20.
go back to reference Arraras JI, et al. EORTC QLQ-COMU26: a questionnaire for the assessment of communication between patients and professionals. Phase III of the module development in ten countries. Support Care Cancer. 2017;25(5):1485–94.CrossRef Arraras JI, et al. EORTC QLQ-COMU26: a questionnaire for the assessment of communication between patients and professionals. Phase III of the module development in ten countries. Support Care Cancer. 2017;25(5):1485–94.CrossRef
21.
go back to reference Liekweg A, et al. Psychometric assessment and application of a questionnaire measuring patient: satisfaction with information on cancer treatment. Pharm World Sci. 2005;27(2):96–103.CrossRef Liekweg A, et al. Psychometric assessment and application of a questionnaire measuring patient: satisfaction with information on cancer treatment. Pharm World Sci. 2005;27(2):96–103.CrossRef
22.
go back to reference Bennett C, et al. Validation of a preparation for decision making scale. Patient Educ Couns. 2010;78(1):130–3.CrossRef Bennett C, et al. Validation of a preparation for decision making scale. Patient Educ Couns. 2010;78(1):130–3.CrossRef
23.
go back to reference Casar D. Evaluation eines Arzt-Patien-Interaktions-Trainings im Krankenhaus anhand von Selbst- und Fremdbeoachtungen. In: Medizinische Fakultät. Ludwig-Maximilians-Universität München; 2009. Casar D. Evaluation eines Arzt-Patien-Interaktions-Trainings im Krankenhaus anhand von Selbst- und Fremdbeoachtungen. In: Medizinische Fakultät. Ludwig-Maximilians-Universität München; 2009.
24.
go back to reference Neumann M, et al. Psychometric evaluation of the German version of the “Consultation and Relational Empathy” (CARE) measure at the example of cancer patients. Psychother Psychosom Med Psychol. 2008;58(1):5–15.CrossRef Neumann M, et al. Psychometric evaluation of the German version of the “Consultation and Relational Empathy” (CARE) measure at the example of cancer patients. Psychother Psychosom Med Psychol. 2008;58(1):5–15.CrossRef
25.
go back to reference Software V. MAXQDA Analytics Pro. Berlin: VERBI; 2016. Software V. MAXQDA Analytics Pro. Berlin: VERBI; 2016.
26.
go back to reference Mayring P. In: überarbeitete Auflage, editor. Qualitative Inhaltsanalyse Grundlagen und Techniken. 9. Weinheim: Beltz Verlag; 2007. Mayring P. In: überarbeitete Auflage, editor. Qualitative Inhaltsanalyse Grundlagen und Techniken. 9. Weinheim: Beltz Verlag; 2007.
27.
go back to reference Flick U. Doing triangulation and mixed methods. The Sage qualitative research kit. Vol. 2nd. Los Angeles: Sage; 2018. Flick U. Doing triangulation and mixed methods. The Sage qualitative research kit. Vol. 2nd. Los Angeles: Sage; 2018.
28.
go back to reference Schofield P, et al. Effectively discussing complementary and alternative medicine in a conventional oncology setting. Communication recommendations for clinicians. Patient Educ Couns. 2010;79(2):143–51.CrossRef Schofield P, et al. Effectively discussing complementary and alternative medicine in a conventional oncology setting. Communication recommendations for clinicians. Patient Educ Couns. 2010;79(2):143–51.CrossRef
Metadata
Title
Evaluation of a blended-learning training concept to train oncology physicians to advise their patients about complementary and integrative medicine (KOKON-KTO): study protocol for a prospective, multi-center, cluster-randomized trial
Authors
Stefanie M. Helmer
Alizé A. Rogge
Felix Fischer
Daniel Pach
Markus Horneber
Stephanie Roll
Claudia M. Witt
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3193-y

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue